Introduction

54
In the UK prostate cancer is the number one male malignancy accounting for 25% of all new 55 cancer diagnoses in men (Siegel, et al. 2012 cancer will become the most common cancer in men globally (Parkin, et al. 2001 ). fundamentally alter endogenous hormones including sex steroids (Barazani, et al. 2014 ).
85
Indeed, factors such as smoking, increased physical exercise and a vegetarian diet increased Another interesting population which is exposed to a high E/T ratio are transsexual male to 187 female individuals. Often in this group of former males, individuals are orchiectomised and 188 then supplemented with anti-androgens to relinquish masculine secondary sex characteristics.
189
They are also supplemented with oestrogens to acquire and enhance feminine characteristics. possible that phytoestrogens reduce the risk of prostate cancer through multiple mechanisms.
246
In rodent models phytoestrogens can upregulate SHBG synthesis in the liver leading to a 247 higher circulating concentration (Pilšáková, et al. 2010 ). Increased SHBG is anti-androgenic
248
as it binds to free testosterone with a higher affinity than oestrogens (Knochenhauer et al. tumours modulates the expression of 17β-HSD-2 and 17β-HSD-5 (and also 3β-HSD). 
Oestrogen receptors (ER) in the prostate
460
The effects of oestrogens on tissues are mediated via activation of oestrogen receptors (ER). decreases proliferation but has no effect on cell viability thus the tumour mass remained 585 static. This further demonstrates that ERα regulates cell proliferation through PI3K and
586
MAPK signalling (Takizawa, et al. 2015) . Intratumoural E 2 can be formed from desulfation and reduction of circulating oestronesulphate (E 1 S) by steroid sulphatase (STS) and 17β-hydroxysteroid dehydrogenase (HSD).
Alternatively, oestrogens can be produced from androstenedione or testosterone by aromatase. Aromatase competes with 5α-reductase (SRD5A1), responsible for potentiating androgens, for these substrates. DHEA, the precursor for androstenedione, is most likely derived from the large pool of circulating DHEAS by STS, as intratumoural synthesis from progestogens remains disputable. 
